Literature DB >> 29483178

Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".

Heinrich Taegtmeyer1, Anja Karlstaedt1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29483178      PMCID: PMC6193270          DOI: 10.1161/CIRCULATIONAHA.117.031193

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.

Authors:  Michael Fralick; Sebastian Schneeweiss; Elisabetta Patorno
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

Review 2.  After avandia: the use of antidiabetic drugs in patients with heart failure.

Authors:  Khaled I Khalaf; Heinrich Taegtmeyer
Journal:  Tex Heart Inst J       Date:  2012

Review 3.  Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Authors:  Heinrich Taegtmeyer; Christophe Beauloye; Romain Harmancey; Louis Hue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

4.  Dramatic reversal of derangements in muscle metabolism and left ventricular function after bariatric surgery.

Authors:  Joshua G Leichman; Erik B Wilson; Terry Scarborough; David Aguilar; Charles C Miller; Sherman Yu; Mohamed F Algahim; Manuel Reyes; Frank G Moody; Heinrich Taegtmeyer
Journal:  Am J Med       Date:  2008-11       Impact factor: 4.965

5.  Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Authors:  Mikhail Kosiborod; Matthew A Cavender; Alex Z Fu; John P Wilding; Kamlesh Khunti; Reinhard W Holl; Anna Norhammar; Kåre I Birkeland; Marit Eika Jørgensen; Marcus Thuresson; Niki Arya; Johan Bodegård; Niklas Hammar; Peter Fenici
Journal:  Circulation       Date:  2017-05-18       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.